Cholera Outbreak Strikes 29 Countries, Highlights Vaccine Shortage

The international group coordinating emergency vaccines recommends administering one dose instead of two to combat the “dire shortage” of cholera vaccines worldwide.

A black and white headshot of Katherine Irving
| 3 min read
a person in a black shirt crouches on a dirt bank and cups water drawn from a river.
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Widespread cholera outbreaks have forced health agencies to ration vaccines, raising questions about affected countries’ public health infrastructure. The disease has already infected hundreds of thousands of people this year, The New York Times reports. As a result, the International Coordinating Group (ICG), which manages the distribution of emergency vaccines and is made up of members of the World Health Organization (WHO) and humanitarian groups such as Doctors Without Borders and UNICEF, has recommended giving out just one vaccine dose per person instead of the full two-dose regimen, the WHO announced in a press release earlier this month (October 19).

Cholera is a bacterial infection typically spread through the ingestion of contaminated food or water. According to the Centers for Disease Control and Prevention (CDC), the main symptoms are profuse diarrhea and vomiting, resulting in severe dehydration. That dehydration leads to kidney failure, shock, and death in 3 percent of cases on average, but outbreaks from the past few years exhibited higher death rates, the Times reports.

According to the WHO press release, cholera cases have been reported in 29 countries this year, with particularly large outbreaks occurring in Haiti, Malawi, and Syria. This a sharp departure from the average of fewer than 20 afflicted countries per year over the past five years, the release adds, stating that flooding, drought, conflict, and human displacement have driven up the infection rate.

The increase in cases has worsened strain on public health infrastructure in the impacted areas, and officials are now figuring out how to distribute a limited supply of vaccines. Of the 36 million cholera vaccine doses slated for production this year, 24 million have already been distributed. Another eight million are approved for emergency vaccination in four of the affected countries, the press release continues. This leaves little room for emergency vaccination in the other affected countries and even less for preventative vaccination in vulnerable neighboring countries, the Times reports. The growing number of cases and “dire shortage” of the vaccine prompted the ICG recommendation for rationing, the WHO release states. While the vaccine’s protective capabilities and the duration of benefit are reduced without the second shot, the release argues that “the benefit of supplying one dose still outweighs no doses.”

“There is just not enough vaccine,” Daniela Garone, the international medical coordinator for the humanitarian organization Doctors Without Borders, tells the Times. “And it’s the chicken or the egg: Do you prevent or you react? At the moment we are only on the reacting, trying to prevent mortality, and we cannot prevent.”

As of today (October 31), France had begun distributing cholera vaccines in Lebanon, Reuters reports. Lebanon had been cholera-free since 1993 until its current outbreak, which likely reached the country from neighboring Syria and was exacerbated by ongoing economic crisis, Reuters adds.

“We have now dedicated 70% of our beds to cholera cases,” Mohamad Khodreen, director of Abdallah Elrassi public hospital in Akkar, Lebanon, tells the BBC. Reuters reports that French ambassador to Lebanon Anne Grillo told reporters that the outbreak was “a new and worrying illustration of the critical decline in public provision of access to water and sanitary services in Lebanon.”

Seth Berkley, the chief executive officer of GAVI, an organization that manages cholera vaccines globally, tells the Times he expects as many as 5 million doses could still be produced by the end of this year, and that as many as an additional 7 million could be made available from canceled requests. Despite growing case counts, the Times reports that cholera treatment can be simple and inexpensive, often requiring only rehydration salts and antibiotics. “Even countries that have not been exposed to cholera before, they can learn quickly,” Garone tells the publication.

Keywords

Meet the Author

  • A black and white headshot of Katherine Irving

    Katherine Irving

    Katherine Irving is an intern at The Scientist. She studied creative writing, biology, and geology at Macalester College, where she honed her skills in journalism and podcast production and conducted research on dinosaur bones in Montana. Her work has previously been featured in Science.
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Image of a woman in a microbiology lab whose hair is caught on fire from a Bunsen burner.
April 1, 2025, Issue 1

Bunsen Burners and Bad Hair Days

Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.

View this Issue
Faster Fluid Measurements for Formulation Development

Meet Honeybun and Breeze Through Viscometry in Formulation Development

Unchained Labs
Conceptual image of biochemical laboratory sample preparation showing glassware and chemical formulas in the foreground and a scientist holding a pipette in the background.

Taking the Guesswork Out of Quality Control Standards

sartorius logo
An illustration of PFAS bubbles in front of a blue sky with clouds.

PFAS: The Forever Chemicals

sartorius logo
Unlocking the Unattainable in Gene Construction

Unlocking the Unattainable in Gene Construction

dna-script-primarylogo-digital

Products

Atelerix

Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China

Green Cooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Thermo Fisher Logo
Singleron Avatar

Singleron Biotechnologies and Hamilton Bonaduz AG Announce the Launch of Tensor to Advance Single Cell Sequencing Automation

Zymo Research Logo

Zymo Research Launches Research Grant to Empower Mapping the RNome